Affiliation: Beth Israel Medical Center
- Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosisPaula Rackoff
Division of Rheumatology, Beth Israel Medical Center, New York, NY 10003, USA
Clin Interv Aging 4:207-14. 2009..The mechanism, efficacy, dosing options, and tolerability of risedronate are reviewed...